The past few years have seen a significant increase in awareness of and interest in chronic obstructive disease. A desire to produce text books summarizing current knowledge naturally follows. This contribution is unusual in its emphasis on visual presentation, plus its use of accompanying CD-ROM.
The book is slickly produced, and figures and tables are clear and cleanly presented. It follows a fairly logical chapter sequence, commencing with basic background introduction, definition and epidemiology, before moving on to pathology and clinical aspects. Appropriate prominence is given to smoking cessation with its own chapter. Drug therapy of stable disease is then tackled, before moving on to management of exacerbations. 'Specialized' treatment of pulmonary rehabilitation, oxygen treatment and surgery follow, before the book closes by describing new drugs for COPD. In examining this organization one is aware of the pharmacological interest of Professor Barnes. One could well argue that pulmonary rehabilitation should be part of mainstream, everyday treatment of COPD, and no more belongs in a 'specialized' treatment section than does, say, tiotropium. On the other hand, dynamic hyperinflation and expiratory flow limitation receive scant attention, despite their undoubted importance and the additional understanding these concepts have given us. Textually, the style is clear and indeed quite dogmatic. This makes the book exceptionally easy to read. Arguments and controversies are not usually debated in depth, but it is very comprehensive the excellent references provide balance. Mostly the text is authoritative. There are however some irritating anomalies. On page 57, FEVy variability is described as typically > 15% in asthma and less than this in COPD, whereas usually the book gives a figure of 12% for significant reversibility, but more rarely settles on the GOLD definition of 12% and at least 200 mL. There is confusion about pre-and postbronchodilator FEVy testing. Page 84 notes that 'prebronchodilator FEV1 is the mainstay of classification of the severity of FEVy' whereas page 108 correctly identifies postbronchodilator FEV1 as the measurement used for staging in the GOLD guidelines. Page 84 also suggests that pre-and postbronchodilator FEV1 is the gold standard for monitoring outcomes of therapeutic interventions, whereas the GOLD guidelines are clear that reversibility testing need only be done once at diagnosis, having no particular value at other times. Page 79 says central cyanosis is manifested as, 'a bluish hue of the lips and fingers at rest'. I would hope my medical students would identify correctly that this is in fact a description of peripheral cyanosis.
The CD-ROM includes both the book itself in pdf format and the illustrations as slides. These can be viewed in three sizes up to full screen, the last ofwhich is legible. In attempting to return to the menu from full screen, use ofthe esc key exits the CD completely, making use more cumbersome than needs be (you can click on a button more succesfully) but the licensing agreement means up to a third may be saved as slides to use for educational reasons, providing a splendid resource.
Who would I recommend this book to? This is a tricky question to answer in terms of individuals. The illustrations provide a valuable aide memoir for the student or junior doctor, but in this case might have been better condensed to a pocket sized publication. The text is certainly clear and readable, and is a concise summary useful for the trainee entering into respiratory medicine. The splendid referencing means it will continue to be useful as the trainee progresses, and for more senior stafftoo. The latter however will appreciate it most for its CD-ROM which I'm sure many would be delighted to have as a resource for teaching. I'd recommend the book as a departmental resource, to allow this varied audience to dip in at will.
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